Single cell-based drug discovery with Greg Ryslik (Celsius Therapeutics)
The Data Pulse
00:00
Understanding Autoimmunity and Cancer
Celsius is aiming to change the paradigm of drug discovery by harnessing advancements in both single cell technologies and in machine learning. Why are these disease areas that are well suited for the use of these technologies? "I think these technologies will be used in a variety of places, not just autoimmunity cancer," he says.
Play episode from 07:05
Transcript
